Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Remedy Q4’25: The stakes are high

Remedy Entertainment

Remedy's investment story is entering a pivotal year, as the company is about to release what is arguably its most important game so far: Control Resonant. For the value creation of Remedy's share, it is essential to succeed with the release. Analyst Atte Riikola summarizes.

Stay up to date
Analyst Interviews

Recent videos

Implantica, Webcast, Q4'25
25.02.2026 klo 16.00 Implantica
Remedy Q4’25: The stakes are high
25.02.2026 klo 14.31 Remedy Entertainment
Gofore, Webcast, Q4'25
25.02.2026 klo 13.00 Gofore
Kamux, Webcast, Q4'25
25.02.2026 klo 11.00 Kamux
Samhällsbyggnadsbolaget, Audiocast, Q4'25
25.02.2026 klo 11.00 Samhällsbyggnadsbolaget i Norden
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.